The software and IT infrastructure services group Novian generated consolidated revenue of EUR 12.5 million in the first half of 2025. While this was lower compared to EUR 15.9 million in the same period last year, profitability remained stable: normalized EBITDA amounted to EUR 1.05 million, and gross profit reached EUR 3.89 million. The group also recorded loss impact on H1 2025 EBITDA - EUR 1.659 million related to a one-off atypical factor that does not affect its normal course of operations. Looking at ...

Global Market Overview - The Hang Seng Index closed at 26,344, down 0.76% for the day but up 31.33% year-to-date [1] - The S&P 500 and Nasdaq in the US saw increases of 0.44% and 0.70% respectively, with year-to-date gains of 13.81% and 18.01% [1] - The Shanghai Composite Index rose by 0.22%, reflecting a year-to-date increase of 14.23% [1] Sector Performance - In the Hong Kong market, the Hang Seng Financial Index fell by 0.85%, while the Hang Seng Industrial and Commercial Index decreased by 0.68% [2] - The Hang Seng Property Index dropped by 1.25%, indicating a year-to-date increase of 23.48% [2] - The energy and consumer staples sectors in the Chinese stock market experienced declines, while materials, healthcare, and information technology sectors saw gains [3] Monetary Policy and Economic Outlook - The People's Bank of China is expected to continue a loose monetary policy, with potential reserve requirement ratio cuts of 50 basis points and interest rate cuts of 10 basis points in Q4 [3] - The steel industry in China will implement capacity controls, prohibiting new capacity additions from 2025 to 2026, with an expected annual growth of around 4% in value added [3] Company Focus - Geely Automobile (175 HK) is rated as a buy with a target price of 25.00, representing a 34% upside potential [4] - Luckin Coffee (LKNCY US) is also rated as a buy, with a target price of 44.95, indicating a 20% upside [4] - Tencent (700 HK) has a target price of 705.00, suggesting a 10% upside potential [4] Technology Sector Insights - Nvidia plans to invest $100 billion to support OpenAI in building a 10GW data center, leading to a nearly 4% increase in its stock price [3] - The semiconductor sector is highlighted with companies like Horizon Robotics (9660 HK) and North Huachuang (002371 CH) rated as buy, with target prices indicating significant upside potential [4] Investment Opportunities - The report identifies several companies with strong growth potential, including BYD Electronics (285 HK) and Salesforce (CRM US), both rated as buy with substantial upside targets [4] - The healthcare sector is represented by companies like BeiGene (ONC US) and 3SBio (1530 HK), both rated as buy, indicating confidence in their future performance [4]

Core Insights - The report highlights a positive outlook for the Chinese internet and software sectors, particularly focusing on the valuation enhancement opportunities within the Chinese internet software segment [4] - The report emphasizes the strong liquidity trends in the A+H stock market and a more optimistic narrative surrounding AI applications, suggesting that AI software applications may match the growth of hardware sectors in the medium to long term [4] Market Performance - The Hang Seng Index closed at 26,545, showing a year-to-date increase of 32.33%, while the Hang Seng Technology Index rose by 40.87% [1] - The report notes mixed performance in the Chinese stock market, with Hong Kong stocks in materials, energy, and consumer discretionary leading gains, while healthcare, utilities, and conglomerates saw declines [3] Sector Analysis - The report identifies key companies in the internet and software sectors that are expected to drive growth, including Alibaba, Baidu, Microsoft, Tencent, and Kuaishou, due to their strong cloud business growth and AI-driven revenue potential [4] - It also suggests that companies like Datadog and Kingdee International have room for valuation improvement and should be monitored for substantial progress in AI monetization [4] Stock Recommendations - The report provides a list of stocks with buy ratings, including Geely Automobile (target price 25.00, current price 18.96), Li Auto (target price 80.00, current price 65.15), and Tencent (target price 705.00, current price 642.00), indicating potential upside [5] - Specific recommendations include companies in various sectors such as healthcare (BeiGene, target price 359.47), consumer staples (Proya, target price 129.83), and technology (Xiaomi, target price 62.96) [5]

2025 年 9 月 17 日 招银国际环球市场 | 市场策略 | 招财日报 每日投资策略 全球市场观察 全球市场观察 全球市场观察 招银国际研究部 邮件：research@cmbi.com.hk 港股分类指数上日表现 | | 收市价 | | 升/跌（%） | | --- | --- | --- | --- | | | | 单日 | 年内 | | 恒生金融 | 45,675 | -0.85 | 29.99 | | 恒生工商业 | 15,108 | 0.84 | 34.29 | | 恒生地产 | 18,991 | -1.46 | 27.35 | | 恒生公用事业 | 36,666 | 0.02 | 2.81 | | 资料来源：彭博 | | | | 敬请参阅尾页之免责声明 请到彭博 (搜索代码: RESP CMBR )或 http://www.cmbi.com.hk 下载更多研究报告 1 环球主要股市上日表现 收市价 升跌（%） 单日 年内 恒生指数 26,439 0.19 31.80 恒生国企 9,386 0.23 28.76 恒生科技 6,078 1.48 36.02 上证综指 3,862 -0.23 15. ...

Global Market Overview - The Hang Seng Index closed at 26,086, down 0.43% for the day but up 30.04% year-to-date [1] - The Shanghai Composite Index rose by 1.65% to 3,875, with a year-to-date increase of 15.62% [1] - The US markets saw the Dow Jones increase by 1.36% to 46,108, with a year-to-date gain of 8.38% [1] Sector Performance - In the Hong Kong market, the healthcare, energy, and consumer discretionary sectors led the decline, while materials, utilities, and industrials saw gains [3] - The semiconductor and rare metals sectors performed notably well, with significant inflows from southbound funds amounting to HKD 189.89 billion [3] Economic Indicators - The European Central Bank (ECB) maintained interest rates and revised down its inflation forecast for 2027 to 1.9% [3] - The US Consumer Price Index (CPI) showed a month-on-month increase of 0.4% and a year-on-year increase of 2.9%, aligning with market expectations [3] Investment Recommendations - Geely Automobile is rated as a "Buy" with a target price of HKD 25.00, representing a potential upside of 33% [4] - Luckin Coffee is also rated as a "Buy" with a target price of USD 44.95, indicating a 19% upside [4] - Semiconductor companies like Horizon Robotics and Beike Micro are rated as "Buy" with target prices of HKD 12.30 and HKD 93.00, respectively, showing potential upsides of 19% and 76% [4]

Group 1: Market Overview - Global markets showed mixed performance, with the Hang Seng Index rising by 1.43% and the S&P 500 declining by 0.32% year-to-date [1][3] - The Chinese stock market saw significant gains, particularly in sectors like materials, healthcare, and industrials, with net inflows of 56.23 billion HKD from southbound funds [3][4] - The U.S. labor market showed signs of weakness, with non-farm payrolls increasing by only 22,000 in August, leading to heightened expectations for interest rate cuts by the Federal Reserve [4][5] Group 2: Industry Insights - The pharmaceutical industry experienced overall weak growth, with average revenue growth of 1.6% and net profit declining by 3.2% in the first half of 2025 [6][8] - The innovative drug sector performed well, with an average revenue growth of 35%, driven by favorable healthcare payment environments and international licensing agreements [6][8] - The CXO sector saw a revenue increase of 15.5% and net profit growth of 32.7%, primarily due to strong demand for GLP-1 products [7][8] Group 3: Company Analysis - Broadcom reported a revenue of 16 billion USD for Q3 2025, exceeding market expectations, with a year-on-year growth of 22% driven by AI semiconductor and VMware business [9][10] - Black Sesame Technologies achieved a revenue of 253 million HKD in the first half of 2025, a 40% increase, although gross margins were under pressure due to unfavorable product mix [11] - The report recommends buying shares in companies like 三生制药 (Sangfor Technologies) and 百济神州 (BeiGene), highlighting their potential for growth in the pharmaceutical sector [12]

Market Overview - The global stock markets showed mixed performance, with the Hang Seng Index closing at 25,059, down 1.12% for the day but up 24.92% year-to-date [1] - The US markets, including the Dow Jones and S&P 500, experienced gains of 0.77% and 0.83% respectively, while the Nasdaq rose by 0.98% [1] - Chinese stock markets faced declines, particularly in hardware technology, with the Shenzhen Composite Index down 2.05% [1][3] Sector Performance - In the Hong Kong market, the Hang Seng Financial Index decreased by 0.42%, while the Hang Seng Industrial Index fell by 1.58% [2] - The hardware technology sector in China led the declines, while sectors such as retail and food saw gains [3] - The US market saw a rise in consumer discretionary, banking, and solar sectors, while utilities and AI-related stocks lagged [3] Company Analysis - Salesforce reported a 10% year-on-year revenue growth to $10.2 billion for Q2 FY26, with non-GAAP net profit increasing by 12% to $2.8 billion, aligning with Bloomberg consensus [4] - The company’s cRPO grew by 11% to $29.4 billion, driven by strong orders from small and medium-sized enterprises [4] - Salesforce's AI and data cloud business saw an impressive annual recurring revenue growth of approximately 120% [4] Investment Recommendations - The report maintains a "Buy" rating for several companies, including Geely Automobile, Li Auto, and Tencent, with target prices indicating significant upside potential [5] - Geely Automobile is rated "Buy" with a target price of 25.00 HKD, representing a 37% upside from its current price of 18.24 HKD [5] - Tencent is also rated "Buy" with a target price of 705.00 HKD, suggesting an 18% upside from its current price of 599.50 HKD [5]

Market Overview - Global markets showed mixed performance, with the Hang Seng Index closing at 25,343, down 0.60% for the day but up 26.34% year-to-date [1] - The Shanghai Composite Index fell by 1.16% to 3,814, while the Shenzhen Composite Index decreased by 1.41% to 2,380 [1] - In the US, the Dow Jones Industrial Average decreased slightly by 0.05% to 45,271, while the S&P 500 rose by 0.51% to 6,448 [1] Sector Performance - The Hang Seng Financial Index fell by 0.72% to 44,195, while the Hang Seng Real Estate Index dropped by 1.23% to 18,116 [2] - The healthcare sector showed resilience, with medical devices and innovative drugs performing well [3] Company Analysis: VILIZHIBO (9887 HK) - VILIZHIBO focuses on developing next-generation immuno-oncology therapies, with a broad product pipeline including immune checkpoint inhibitors and T-cell engagers [4] - The company has established proprietary platforms for drug innovation, including the LeadsBody platform for CD3 T-cell engagers and the X-body platform for 4-1BB agonists [4] - LBL-024, targeting PD-L1/4-1BB, is in the registration clinical stage and shows promising clinical data, with an overall response rate (ORR) of 33.3% in specific cancer patients [5] Company Analysis: China Life (2628 HK) - China Life reported a net profit increase of 7% to 40.9 billion RMB for the first half of 2025, despite a 31% decline in Q2 due to rising insurance service costs [7] - The new business value grew by 20.3% to 28.5 billion RMB, driven by significant growth in bancassurance channels [8] - The company’s core equity assets increased, benefiting from realized capital gains and dividend income [8] Company Analysis: JS Global (1691 HK) - JS Global's SharkNinja brand continues to see high growth in the Asia-Pacific region, with market share in Australia and New Zealand increasing significantly [10] - The company is shifting focus from scale to profitability, with expectations of improved gross and net margins due to product upgrades and SKU optimization [11] - Despite a slight decline in sales, the company anticipates a recovery in overseas sales and improved profitability in the coming years [12]

Global Market Overview - The Hang Seng Index closed at 25,177, down 0.37% for the day but up 25.51% year-to-date [1] - The S&P 500 closed at 6,449, down 0.01% for the day and up 9.65% year-to-date [1] - The Shanghai Composite Index rose by 0.85% to 3,728, with a year-to-date increase of 11.23% [1] Industry Insights - The healthcare sector showed resilience, with major life sciences companies reporting better-than-expected performance in 2Q25, leading to upward revisions in annual guidance [5][6] - The pharmaceutical industry is facing pressure on profit margins due to external factors, but major pharmaceutical companies continue to invest in R&D, indicating a stable outlook for innovation [8] - The retail sector in the U.S. demonstrated resilience with a monthly growth rate increase from 0% in the first half of the year to 0.7% in July, indicating strong consumer spending [4] Company Analysis - Tongcheng Travel reported a total revenue of RMB 4.7 billion in 2Q25, a 10% year-on-year increase, with adjusted net profit rising by 18% to RMB 775 million, exceeding expectations [8] - Xtep's sales for the first half of 2025 grew by 7% to RMB 6.8 billion, with net profit increasing by 21% to RMB 913 million, surpassing forecasts [13] - Leap Motor achieved a revenue of RMB 14.2 billion in 2Q25, a 42% quarter-on-quarter increase, marking its first positive operating profit [14] Investment Ratings - Leap Motor is rated as a "Buy" with a target price of HKD 80, reflecting a strong growth outlook driven by new model launches and expanding sales [14] - Xtep maintains a "Buy" rating with a target price of HKD 7.39, supported by robust sales performance and operational efficiency [12] - Tongcheng Travel is also rated as a "Buy," with a target price of HKD 24.00, based on its strong core business performance [8]

Group 1: Stock Recommendations - Geely Automobile is rated as a "Buy" with a target price of HKD 25.00, representing a potential upside of 25%[5] - Li Auto is rated as a "Buy" with a target price of HKD 72.00, indicating a potential upside of 7%[5] - Sany International is rated as a "Buy" with a target price of HKD 8.70, suggesting a potential upside of 22%[5] - Luckin Coffee is rated as a "Buy" with a target price of USD 44.95, indicating a potential upside of 17%[5] - Tencent is rated as a "Buy" with a target price of HKD 705.00, representing a potential upside of 19%[5] Group 2: Performance Overview - The basket of 26 long positions had an average return of 4.7%, compared to the MSCI China Index return of 5.2%[10] - Out of the 26 stocks, 11 stocks outperformed the benchmark[10] - The report includes a total of 26 stocks with varying sectors such as automotive, technology, and healthcare[5]